PremiumMarket NewsM & A News: Pfizer (NYSE:PFE) to Seal $43B Seagen Deal, Analyst Remains Upbeat Take-Two to be added to Nasdaq-100 index, Seagen to be removed at open on 12/18 Pfizer’s acquisition of Seagen receives all regulatory approvals PremiumThe FlyCantor biotech/biopharma analysts hold analyst/industry conference call Cantor biotech/biopharma analysts hold analyst/industry conference call Seagen highlights first solid tumor data for ADCETRIS combination PremiumThe FlyBiotech Alert: Searches spiking for these stocks today Pfizer (NYSE:PFE) Slides despite EU Nod to Seagen Acquisition Pfizer receives unconditional approval for Seagen acquisition from EU 
